Diopter Technologies
Diopter Technologies is a medical device company focused on developing innovative therapeutic solutions for ophthalmic conditions. The company's core areas include drug delivery via advanced contact lens technologies and dissolvable amniotic membrane biopolymer devices to treat ocular surface diseases, injuries, and post-surgical recovery. By integrating drug delivery with lens design, Diopter Technologies aims to improve patient outcomes, enhance compliance, and provide convenient non-surgical alternatives for eye care.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Drug-delivering contact lens
A therapeutic contact lens embedded with medication, releasing controlled doses directly to the eye for targeted treatment of various eye diseases.
Amnion-based dissolvable contact lens
A contact lens composed of amniotic membrane material designed to dissolve, releasing bioactive factors for ocular surface healing and inflammation reduction.
Bio2020
A dual layer contact lens integrating amnion and bioresorbable polymer for therapeutic treatment of corneal and ocular wounds.
Cat3560
A contact lens capable of releasing a combination of three drugs to manage post-cataract surgery recovery.
Mox5050
A contact lens engineered for release of the antibiotic moxifloxacin to treat corneal infection and abrasions.
Drug-delivering contact lens
A therapeutic contact lens embedded with medication, releasing controlled doses directly to the eye for targeted treatment of various eye diseases.
Amnion-based dissolvable contact lens
A contact lens composed of amniotic membrane material designed to dissolve, releasing bioactive factors for ocular surface healing and inflammation reduction.
Bio2020
A dual layer contact lens integrating amnion and bioresorbable polymer for therapeutic treatment of corneal and ocular wounds.
Cat3560
A contact lens capable of releasing a combination of three drugs to manage post-cataract surgery recovery.
Mox5050
A contact lens engineered for release of the antibiotic moxifloxacin to treat corneal infection and abrasions.
Expertise Areas
- Ophthalmic drug delivery
- Contact lens-based therapeutics
- Ocular surface disease management
- Biomaterial engineering for eye care
Key Technologies
- Drug-eluting contact lens
- Dissolving amniotic membrane biopolymer
- Biocompatible polymers
- Combination device-drug delivery
News & Updates
Presentation of a dissolving biopolymer amniotic membrane device for ocular wound treatment at MedDevice Boston.
Announcement of successful completion of a clinical study evaluating a dissolving contact lens for ocular surface disease.
Showcased new ocular drug delivery technology at a Department of Defense forum dedicated to vision injury research.
Article detailing the upcoming presentation and the technical overview of the dissolving biopolymer device.
Article summarizing the clinical study completion and technology background for the dissolving therapeutic lens.
Coverage of drug delivery technology presentation at a major vision research event.
Presentation of a dissolving biopolymer amniotic membrane device for ocular wound treatment at MedDevice Boston.
Announcement of successful completion of a clinical study evaluating a dissolving contact lens for ocular surface disease.
Showcased new ocular drug delivery technology at a Department of Defense forum dedicated to vision injury research.
Article detailing the upcoming presentation and the technical overview of the dissolving biopolymer device.
Article summarizing the clinical study completion and technology background for the dissolving therapeutic lens.
Coverage of drug delivery technology presentation at a major vision research event.